New Drug A Potential Treatment For Type 2 Diabetes

Links shared publicly online about this topic.

  • 857
    total visits

New Drug A Potential Treatment For Type 2 Diabetes

medicalnewstoday.com

Australian scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes.Drs G

View full resource at medicalnewstoday.com

Tags: Diabetes, Type 2 Diabetes, Drug, Pharma, Scientist, Science

  • Share

Most Recently Shared on September 21, 2010 at 1:05 pm By:

mnt_clinical MNT Clinical Trials

New Drug A Potential Treatment For Type 2 Diabetes http://mnt.to/3K4G #clinicaltrials

2 years ago...

Also Shared By:

MNT Health News MNT Health News

MNT Diabetes News MNT Diabetes News

MNT Endocrinology MNT Endocrinology

BMC Clinical Pharmacology | Abstract | Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial

biomedcentral.com — “Consistent with its effect on gastric emptying, exenatide, an injectable treatment for type 2 diabetes, may slow the absorption rate of concomitantly administered oral drugs resulting in a decrease in maximum concentration (Cmax). This study evaluated the drug interaction potential of exenatide when administered adjunctively with oral contraceptives, given their potential concomitant use.View full resource at biomedcentral.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 9:35 pm By:

Glycosmedia Jim Health News

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive http://t.co/NtAJ9ZIb

4 weeks ago...

FDA approves extended-release tablets for type 2 diabetes - - Drug Topics

drugtopics.modernmedicine.com — “FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on February 6, 2012 at 2:13 am By:

Diabetes_Type2 Diabetes, Type 2 OW Health

FDA approves extended-release tablets for type 2 diabetes: FDA approved sitagliptin and metformin hydrochloride ... http://t.co/5Kio7lsL

2 months ago...

Victoza on the Rise: Paula Deen Promotes Type 2 Diabetes Drug | A Sweet Life

asweetlife.org — “Paula Deen has been privately suffering from type 2 diabetes for three years. Now she’s gone public with both her diabetes and her treatment with Victoza in a new Novo Nordisk initiative.View full resource at asweetlife.org

  • View Related
  • Share

Most Recently Shared on January 17, 2012 at 2:09 pm By:

New hope for diseases of protein folding such as Alzheimer’s, Parkinson’s diseases, ALS, cancer and diabetes

sciencedaily.com — “Two related studies offer new strategies for tackling the challenges of preventing and treating diseases of protein folding, such as Alzheimer's, Parkinson's and Huntington's diseases, ALS, cystic fibrosis, cancer and type 2 diabetes. The research identifies new genes and pathways that prevent protein misfolding and toxic aggregation, keeping cells healthy, and also identifies small molecules with therapeutic potential that restore health to damaged cells, providing new targets for drug developmView full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on January 9, 2012 at 11:40 am By:

GFMelissa Melissa Patient Expert

New hope for protein folding diseases such as Alzheimer’s, Parkinson’s: http://t.co/VuOvO2gv

3 months ago...

New Type 2 Drug Targets Blood Sugar and Cholesterol - Diabetes Health

diabeteshealth.com — “Diabetes Health - Research: US Food and Drug Administration. The new therapy, called Juvisync, was just approved by the US Food and Drug Administration. It\'s not a radical new treatment, but instead a helpful combination of two familiar standbys: Juvisync unites the active ingredients in blood sugar-lowering Januvia and cholesterol-lowering Zocor in a single tablet.View full resource at diabeteshealth.com

  • View Related
  • Share

Most Recently Shared on December 15, 2011 at 6:11 pm By:

DiabetesHealth Diabetes Health Health Site

New Type 2 Drug Targets Blood Sugar and Cholesterol - Diabetes Health http://t.co/6i3v3QCT

4 months ago...

NIH-funded project to discover biomarkers for type 2 diabetes

news-medical.net — “Arizona State University will lead a four-year, $5 million expanded initiative sponsored by the National Institutes of Health to discover proteins, or biomarkers, to help predict cardiovascular disease and to assess potential new treatments in people with type 2 diabetes.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 2, 2011 at 1:58 pm By:

Stroke_News News-Medical.Net Health News

Stroke News: NIH-funded project to discover biomarkers for type 2 diabetes: Arizona State University will lead a... http://t.co/p00y18RH

5 months ago...

Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today

medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatmentView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 19, 2011 at 9:33 pm By:

Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today

medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatmentView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 17, 2011 at 6:02 pm By:

ysijp Yvo Sijpkens MD Doctor, Internist, Nephrologist, and Physician

Gliptins show a 30% relative risk reduction of suffering a major cardiac event. http://t.co/LwJ12Qxu @diabetes

7 months ago...

Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today

medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatmentView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 16, 2011 at 9:17 pm By:

MedicalNews Medical News Health News

EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers (CME/CE) http://t.co/wUsmdYno

7 months ago...

Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today

medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatmentView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 16, 2011 at 9:08 pm By:

MedicalFeed MedicalFeed Health News Feed

EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers (CME/CE): LISBON (MedPage Today) -- While… http://t.co/wjbooIio

7 months ago...

New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com — “New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.comView full resource at keyvive.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 7:26 am By:

keyvive Aimee Greenholtz ePatient

New drug for those at risk for a stroke: Apixaban may trump standard treatment in preventing… http://t.co/AScyCH0

7 months ago...

New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com — “New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.comView full resource at keyvive.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 7:26 am By:

keyvive Aimee Greenholtz ePatient

New drug for those at risk for a stroke: Apixaban may trump standard treatment in preventing… http://t.co/Pt7zdpG

7 months ago...

New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com — “New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.comView full resource at keyvive.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 7:26 am By:

keyvive Aimee Greenholtz ePatient

New drug for those at risk for a stroke: Apixaban may trump standard treatment in preventing… http://t.co/2MVh1Bq

7 months ago...

New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com — “New drug for those at risk for a stroke | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.comView full resource at keyvive.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 7:26 am By:

keyvive Aimee Greenholtz ePatient

New drug for those at risk for a stroke: Apixaban may trump standard treatment in preventing… http://t.co/6sV8gVu

7 months ago...

New target against type 2 diabetes and prediabetes identified - Yahoo!

in.news.yahoo.com — “Read 'New target against type 2 diabetes and prediabetes identified' on Yahoo!. Washington, August 23 (ANI): Researchers at the Joslin Diabetes Center have identified a new drug target for treatment of type 2 diabetes and prediabetes.View full resource at in.news.yahoo.com

  • View Related
  • Share

Most Recently Shared on August 23, 2011 at 3:55 pm By:

Diabetes_Type2 Diabetes, Type 2 OW Health

New target against type 2 diabetes and prediabetes identified: Washington, August 23 (ANI): Researchers at the J... http://t.co/ab2tpJk

8 months ago...

Advertisement